n-acetylglucosaminono-1,5-lactone o-(phenylcarbamoyl)oxime has been researched along with cyclin d1 in 1 studies
| Studies (n-acetylglucosaminono-1,5-lactone o-(phenylcarbamoyl)oxime) | Trials (n-acetylglucosaminono-1,5-lactone o-(phenylcarbamoyl)oxime) | Recent Studies (post-2010) (n-acetylglucosaminono-1,5-lactone o-(phenylcarbamoyl)oxime) | Studies (cyclin d1) | Trials (cyclin d1) | Recent Studies (post-2010) (cyclin d1) |
|---|---|---|---|---|---|
| 88 | 0 | 36 | 10,885 | 70 | 5,157 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jóźwiak, P; Krześlak, A; Lipińska, A | 1 |
1 other study(ies) available for n-acetylglucosaminono-1,5-lactone o-(phenylcarbamoyl)oxime and cyclin d1
| Article | Year |
|---|---|
Down-regulation of β-N-acetyl-D-glucosaminidase increases Akt1 activity in thyroid anaplastic cancer cells.
Topics: Acetylglucosamine; beta-N-Acetylhexosaminidases; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cyclin D1; Down-Regulation; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Humans; Insulin-Like Growth Factor I; Oximes; Phenylcarbamates; Phosphorylation; Proto-Oncogene Proteins c-akt; RNA Interference; Thyroid Neoplasms | 2011 |